
News|Articles|February 2, 2005
- Pharmaceutical Technology-02-02-2005
- Volume 29
- Issue 2
Toward a Generic Approach for Stress Testing of Drug Substances and Drug Products
The Impurity Profiling Group reviews stress testing according to regulatory guidance documents. The authors emphasize what should be considered for late clinical phases and for registration application dossiers.
Advertisement
Articles in this issue
about 21 years ago
Correcting the Courseabout 21 years ago
February 2005about 21 years ago
Good Work and True: USP Prepares for Convention 2005about 21 years ago
Contract Manufacturers Getting Squeezedabout 21 years ago
In the Spotlight-February 2005about 21 years ago
Emerging Analytical Technology: Moving from the Lab to the Lineabout 21 years ago
Drug Safety Fears May Limit Reimporting and Shape R&Dabout 21 years ago
In Defense of USP Singlet TestingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
2
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
3
PharmTech Weekly Roundup - February 6, 2026
4
Women in STEM: Early Phase Drug Development
5




